Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 34104

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2022 | Month : July | Volume : 16 | Issue : 7 | Page : EC36 - EC41 Full Version

Significance of Glomerular C1q deposits in IgA Nephropathy


Published: July 1, 2022 | DOI: https://doi.org/10.7860/JCDR/2022/53066.16666
Divya Radhakrishnan, NK Supriya, M Sreelatha, KP Aravindan

1. Senior Resident, Department of Pathology, Government Medical College, Kozhikode, Kerala, India. 2. Professor, Department of Pathology, Government Medical College, Kozhikode, Kerala, India. 3. Professor, Department of Nephrology, Government Medical College, Kozhikode, Kerala, India. 4. Professor, Department of Pathology, Government Medical College, Kozhikode, Kerala, India.

Correspondence Address :
Dr. Divya Radhakrishnan,
Thekkemoozhickal House Sree Nararayana Road, Edappally PO, Kochi 682024, Ernakulam, Kerala, India.
E-mail: divyarlakshmi@gmail.com

Abstract

Introduction: Immunoglobulin A (IgA) nephropathy is the most common form of glomerulonephritis in young men, often presenting as gross or microscopic haematuria and accounts for approximately 10% of the patients with End-Stage Renal Disease (ESRD). The contribution of the complement system to amplify tissue injury in IgA nephropathy has been suggested but the precise pathways of complement activation especially the involvement of classical pathway remain largely unknown.

Aim: To determine the prevalence of glomerular C1q deposition in IgA nephropathy to delineate the relationship of glomerular C1q positivity and different histological variables indicating disease activity and disease progression and also to determine the relationship of glomerular C1q positivity and the Oxford scoring system in IgA nephropathy.

Materials and Methods: This was a prospective study conducted over a period of three years {January 2014- December 2016} in the Department of Pathology with the cooperation of the Department of Nephrology at Government Medical College, Kozhikode , Kerala, India. A total of 44 cases which were both biopsy and immunofluorescence proven as IgA nephropathy were included in the study. For light microscopy, the tissue received in buffered formalin was processed into paraffin blocks, stained with Haematoxylin and Eosin (H&E) and histopathological changes analysed. For immunofluorescence, tissue received in normal saline was frozen in cryostat and 3 μm sections were stained using the Dako polyclonal Fluorescein Isothiocyanate (FITC) conjugated antibodies IgG, IgM, IgA, C3, C1q and studied for pattern of glomerular staining. Chi-square test was used for statistical analysis.

Results: The prevalence of C1q deposits was 27.3%. Among histopathological variables, only fibrous crescent was found to have significant relationship with C1q positivity (p= 0.0472). On follow-up, 50% C1q positive patients and 11.76% C1q negative patients who were having normal renal functions at the start of the study went into renal insufficiency.

Conclusion: The study revealed that there was a fairly high prevalence of C1q deposits in IgA nephropathy patients. Also, significant association was found between C1q deposits and fibrous crescent. Most significantly the study concluded that there is an increased tendency for the C1q positive patients to go into renal failure.

Keywords

Complement, Crescent, Immunofluorescence, Mesangium

IgA nephropathy was recognised as a distinct entity by Berger J and Hinglais N (1). The initiating event in the pathogenesis of IgA nephropathy is the mesangial deposition of IgA. A widely stated hypothesis is that mucosal antigenic exposure in a genetically susceptible individual results in the generation of nephritogenic IgA antibodies that form complexes in the circulation and get deposited in glomeruli which is predominantly polymeric IgA of the IgA1 subclass (pIgA1) leading to glomerular injury. The prevalence, clinical course and outcomes are highly variable when compared between different regions of the world. Evidence obtained from research on immunogenetics as well as studies on racial differences in prevalence, and familial occurrence of IgA nephropathy strongly supports the role of genetic factors in the development and progression of the IgA nephropathy (2). Mesangial deposition of IgA is the initiating event followed by complement activation (3). IgA nephropathy is usually accompanied by C3 deposition (4). The alternative pathway of the complement activation is implicated due to the absence of C1q and C4 (5),(6). In a study by Gunnarsson I et al., no correlations were observed between anti-C1q levels and renal function of IgA nephropathy patients (7). Welch TR and McAdams J in their paper on childhood IgA nephropathy found that mesangial deposits of IgM or C1q which are seen frequently, probably due to heavy proteinuria at the time of biopsy, and do not contribute adversely to outcome (8). An association between IgA nephropathy and the HLA Bw35 (Human Leucocyte Antigen) was initially reported in small Australian and French cohorts which was supported by several reports of twins with IgA nephropathy who shared the HLA-antigen Bw35 (9). A higher prevalence has been noted in Asia including India and hence it can infer that environmental and genetic factor contribute to disease progression. Initially thought as benign, it is known to lead to ESRD (10),(11). A few studies have put forward the activation of the lectin pathway in IgA nephropathy cases (12),(13). Glomerular deposits of IgA are accompanied by C3 but rarely by C1q (8). However, mesangial C1q deposition has been reported to be associated with a poor renal outcome in patients with IgA nephropathy (14). Thus, there is no uniformity regarding the effect of C1q deposition in IgA nephropathy on outcome and renal histology. No similar studies have been done in Indian patients. So, the aim of the study was to look at the prevalence of C1q deposition in IgA nephropathy and its relation to various histological parameters and the Oxford scoring system (15).

Material and Methods

The present study was a prospective study conducted in the Department of Pathology with the cooperation of the Department of Nephrology at Government Medical College, Kozhikode, Kerala, India, over a period of three years {January 2014- December 2016}. A total of 44 cases were selected during January 2014 to March 2015 and followed-up for six months to two years. Ethical clearance for the study was obtained from Institutional Ethics Committee (IEC), Government Medical College, Koshikode. (Ref. No. GMCKKD/RP 2014/IEC/26/01 -22/1/2014). Informed consent was taken from all the participants.

Inclusion criteria: Cases of biopsy and immunofluorescence proven IgA nephropathy diagnosed were included in the study.

Exclusion criteria: Those with secondary causes of mesangial IgA deposits such as Henoch Schonlein Purpura (HSP) and Systemic Lupus Erythematous (SLE), patients with ESRD at the time of diagnostic biopsy, diseases other than IgA nephropathy, like Diabetes mellitus, cases in which immunofluorescence was not done and inadequate tissue were excluded.

The medical records and the referral forms submitted at the time of biopsy from the Department of Nephrology were reviewed and the following information at the time of the renal biopsy recorded: patient age, sex, presence or absence of hypertension, Urine Protein Creatinine Ratio (PCR), Urine microscopy, Serum creatinine level, Serum complement and Haemoglobin levels.{anaemia was defined as haemoglobin <13 g/dL in males and <12 g/dL in females (16). Hypertension was defined as systolic blood pressure >120 mmHg and diastolic blood pressure >80 mmHg or taking antihypertensive (17). Nephrotic range proteinuria was defined as Urine PCR >200 mg/mmol (18). Glomerular Filtration Rate (GFR) was estimated in all the patients by the (Chronic Kidney Disease Epidemiology Collaboration) CKD-EPI formula. Normal Glomerular filtration rate (GFR) was defined ≥90 mL/min/1.73m2. Renal insufficiency was defined as (estimated GFR) eGFR <60 mL/min/1.73 m2. ESRD was defined as severe irreversible kidney damage and (estimated GFR) eGFR <15 mL/min/1.73 m2 (18), Hypocomplimentemia was defined as serum C3 <80 mg/dL (19)}

The patients were seen in the Nephrology OPD for follow-up assessment. They were followed-up for six months to two years.

Histological evaluation of renal lesions was done in each patient enrolled for this study. For light microscopy, the tissue submitted was fixed in buffered formalin and processed into paraffin blocks, sections were stained with H&E. Special stains (Periodic Acid Schiff) were done to identify necrosis and expansion in mesangial matrix and also help to distinguish mesangial hypercellularity associated with sclerosis from end capillary lesion. Initially, histopathological variables in Oxford classification were assessed (15) (Table/Fig 1).

Also, renal biopsy was arbitrarily divided the into three compartments as glomerulus, interstitium, and vascular. The histopathological changes in these compartments excluding those considered under the Oxford classification were separately analysed.

Glomeruli

1. Mesangial matrix increase
2. Capillary narrowing or disruption
3. Cellular crescents
4. Fibrous crescents
5. Any crescent

Tubulointerstitial compartment

1. Interstitial infiltrates
2. Interstitial oedema
3. Tubular dilation
4. Vacuolisation

Vessels

1. Intimal thickening (assessed by comparing thickness of intima relative to total medial thickness) (20).
2. Medial hypertrophy (comparing thickness of the muscular wall relative to the vascular calibre) (21).

For immunofluorescence, tissue received in a separate bottle containing normal saline was frozen in the cryostat. The pattern of glomerular staining was studied using the Dako polyclonal FITC conjugated antibodies (IgG, IgM, IgA, C3, C1q). The immunofluorescence intensity in the mesangial area was graded on a 4-point scale: grade 0-absent; grade 1-weak; grade 2-moderate; grade 3-severe. (Visual grading based on the brightness of immunofluorescence). Mesangial deposits of immunoglobulin’s and complement showing grade 1 to grade 3 fluorescence were considered positive (22).

Statistical Analysis

The data was entered in Excel 7 and the results were analysed using EPI INFO software, Chi-square test was applied and p-value was calculated. p<0.05 was considered significant.

Results

A total of 44 cases were included in the study. Cases were serologically and clinically negative for SLE, 34 out of 44 cases belonged to the 11-40 age groups as shown in (Table/Fig 2). The majority of the patients with IgA nephropathy were males constituting 27 (61.34%) of cases. Cases were divided into two groups according to the presence of C1q deposition: C1q positive (n=12) and C1q negative (n=32). Immunofluorescence findings are shown in (Table/Fig 3), (Table/Fig 4) and representative images are shown in (Table/Fig 5), (Table/Fig 6), (Table/Fig 7). The relationship between various clinical parameters and renal morphological variables with C1q positivity was analysed (Table/Fig 8). A total of 12 out of 44 cases (27.3%) showed C1q deposits in mesangium and C1q deposits were more commonly seen in females (7 out of 17 cases) but this did not show any statistical significance (p-value 0.09). The majority of patients diagnosed with IgA nephropathy were anaemic (28 out of 44 patients). However, anaemia was also not statistically significant since p-value >0.05. Among the 44 cases of IgA nephropathy, 18 cases had an initial presentation as haematuria of which only 4 cases were C1q positive. Two out of 44 cases of IgA nephropathy patients had complement levels less than 83 and they were C1q negative. Out of 44 cases studied, 23 patients had initial renal insufficiency and majority were C1q negative. None of the variables of oxford classification were statistically significant in comparison with C1q positivity (Table/Fig 9), (representative image of segmental glomerulosclerosis is shown in (Table/Fig 10). The only histopathological variable which showed significant association with C1q positivity was fibrous crescent (p-value=0.04) (Table/Fig 11), (Table/Fig 12), (representative image of fibrous crescent is shown in (Table/Fig 13). On follow-up, 2 out of 4 (50%) C1q positive patients and 2 out of 17 (11.76%) C1q negative patients who were having normal renal functions at the start of the study went into renal insufficiency.

Discussion

In the present study, IgA nephropathy showed a predilection for the range of 31-40 years and most of the patients were in the age range of 11-40 years. Rajasekaran A et al., and Khairwa A et al., in their study found that IgA nephropathy peaks during first three decades of life (23),(24). Many studies have shown older age to be a predictor of a worse prognosis (25),(26),(27),(28),(29). On the other hand, few studies have shown a worse prognosis in younger patient (30),(31),(32). There was a male preponderance among IgA nephropathy cases in this study as in the previous studies (23),(33). This study did not show any significant association of age with C1q deposits. Among 44 patients who were diagnosed with IgA nephropathy, (27.3%) showed C1q deposits in mesangium. These cases were serologically and clinically negative for SLE. An Indian study demonstrated three cases of IgA nephropathy with C1q deposits and they were also serologically and clinically negative for SLE (11). More research is warranted to determine whether the prevalence of C1q deposits is high in the IgA nephropathy cases among Indian population.

Glomerular deposits of IgA in IgA nephropathy are usually accompanied by C3 deposition (8). A similar picture was obtained in this study too. Mesangial C3 deposition was not statistically significant when compared with C1q deposits since both C1q negative and positive cases showed almost equal percentages of C3 deposition with a p-value of 0.52. Welch TR stated in their paper that IgA nephropathy, in which mesangial C1q was detected, was accompanied by IgM and tends to occur in patients with significant proteinuria, suggesting possible non specific trapping rather than true activation of the classical pathway (8). The study by Wada Y et al., concluded that mesangial IgG co-deposition with IgA is associated with a bad prognosis in IgA nephropathy (34). In this study no significant association was obtained between C1q deposits and IgM deposition.

Among the 44 cases of IgA nephropathy, 18 cases had an initial presentation as haematuria. Of these, 4 cases were C1q positive and 14 cases were C1q negative. Generally, the degree of haematuria has apparent bearing on the severity or likelihood of progression of IgA nephropathy. However in the present study, there was no significance of haematuria with C1q deposit (p-value 0.39). Though hypertension was not statistically significant in this study, hypertension is an independent predictor of progression to ESRD by multivariate analysis in almost all studies in which such analysis was performed (29),(35),(36). In a similar study, it was found that C1q patients had higher mean systolic pressure values than unmatched C1q negative patients (10),(37),(38),(39),(40). The majority of patients diagnosed with IgA nephropathy were anaemic (28 out of 44 patients). As per the study 9 out of 12 (75%) C1q positive patients were anaemic compared to 19 out of 32 C1q negative patients. However, anaemia was also not statistically significant (p-value=0.27). Proteinuria at presentation is considered as a strong predictor of unfavourable outcome and patients with IgA nephropathy with mesangial C1q deposition had more proteinuria when compared with C1q negative group (28),(29). though present study did not show any significant association with C1q deposits (p-value 0.62). Two out of 44 cases of IgA nephropathy patients had complement levels less than 80 and these two cases were C1q negative. Out of 44 cases studied, 23 patients had initial renal insufficiency. Among these, eight cases were C1q positive and 15 cases C1q negative. Though it was not statistically significant (p-value=0.20). According to one study, the greater percentage of patients with renal insufficiency was C1q positive (66.7%) compared to C1q negative patients (46.9%). Baseline levels of serum keratinise, total cholesterol, 24-hour urine protein, low-density lipoprotein, β2 macroglobulin were found to be higher in C1q positive cases when compared with those in C1q negative group (41).

The Oxford classification of IgA nephropathy identified four histological features, which are independent predictors of clinical outcome (15). However, in this study, no significant association was found between C1q deposits and variables of Oxford classification - M (p-value=0.27), E (p-value=0.52), S (p-value=0.46) and T (p-value=0.93). But, statistical analysis of histopathological variables revealed a significant association (p-value=0.04) between C1q deposits and fibrous crescent. Similarly, a fair correlation of crescents with serum creatinine was put forward by Mubarak M and Trimarchi H et al., in their research paper and this lesion was included in the revised version of the Oxford classification (42),(43). Tan L et al., in their study concluded that the risk factors which predicted poor renal survival in IgA nephropathy were serum creatinine, urinary protein and mesangial C1q deposition (44).

Interstitial infiltrates is associated with heavy proteinuria and decreased renal function in IgA nephropathy patients though in the present study no significance was found (45). Tubular necrosis is associated with dilation of the lumen, desquamation of lining epithelial cells cytoplasmic degeneration and nuclear pyknosis. Tubular damage is associated with incomplete recovery of renal function though this factor was not significant in the present study (29). Intimal thickening, medial hypertrophy and arteriolar hyalinosis of interlobar arteries has been reported in patient with IgA nephropathy and Prader Willi syndrome (46). Intrarenal arterial lesions like arterial intimal thickening and arteriolar hyalinosis is associated with poorer renal outcomes (47), though found insignificant in the present study. Study by Dong L et al., concluded that intrarenal arterial and arteriolar lesions including intimal thickening was found in 40-45% of IgA nephropathy patients which can lead to chronic hypoxia and renal injury (48). Another study by Wu et al., also concluded that intensity of arterial-arteriolar lesions is associated with adverse outcomes (49). However, in the original Oxford study, arterial and arteriolar lesions described as artery score is not related to renal outcome adversely (15).

On follow-up, 2 out of 4 (50%) C1q positive patients and 2 out of 17 (11.76%) C1q negative patients who were having normal renal functions at the start of the study went into renal insufficiency. Thus, it can be inferred that there is an increased tendency for C1q positive patients to go into renal failure. A similar study by Lee HJ et al., and Tan L et al., concluded that mesangial C1q deposition in the glomerulus is associated with a poor renal outcome and hence it could therefore serve as an indicator of poor renal prognosis (14),(44). Another study found that the C1q deposits found in 0-45% cases of IgA nephropathy and the absence of C1q deposition in the mesangial area in patients with IgA nephropathy is a novel positive predictive marker for the response to tonsillectomy plus steroid pulse therapy (50). Mesangial C1q deposition may be triggering persistent inflammatory response which can lead to endothelial proliferation and cellular crescent formation. In the absence of therapy, these pathological lesions can transform into chronic renal fibrosis. Hence, mesangial C1q deposition in IgA nephropathy patients should be considered as an indication of aggressive disease, and thus requires treatment with corticosteroids or immunosuppression (41). A retrospective study was carried out in Shanxi Medical University which also concluded that C1q deposits are an independent risk factor which greatly influenced the renal outcome in IgA nephropathy (41).

Activation of the complement system is the main culprit behind IgA nephropathy (6). Classical complement pathway gets activated after binding of C1q to immune complexes. C1q deposition rates vary in IgA nephropathy patients and this variation among cases may be explained by the differences in race, age, gender ratio, urine protein and methods of analysis (14). Since C1q deposits are not essential for the definitive diagnosis of IgAN, the clinical importance of C1q is not yet studied. Hence, further research is warranted to study the significance of C1q as a prognostic tool in IgAN.

Limitation(s)

The limitations of the study were small sample size and the short follow-up period.

Conclusion

In this study prevalence of C1q deposits in IgA nephropathy patients was found to be 27.3%. Significant association was found between C1q deposits and fibrous crescent. 50% of C1q positive patients in this study went in to renal insufficiency thus it can be inferred that there is an increased tendency for C1q positive patients to go into renal failure. Hence C1q deposits can be considered as a novel prognostic indicator in IgA nephropathy patients. Thus, research to bring out the involvement of the classical pathway of complement activation is highly recommended in Indian scenario.

References

1.
Berger J, Hinglais N. Intercapillary deposits of IgA-IgG. J Urol Nephrol (Paris). 1968;74(9):694-95. [crossref] [PubMed]
2.
André C, Berthoux FC, André F, Gillon J, Genin C, Sabatier JC. Prevalence of IgA2 deposits in IgA nephropathies: A clue to their pathogenesis. N Engl J Med. 1980;303(23):1343-46.
3.
Hall RP, Stachura I, Cason J, Whiteside TL, Lawley TJ. IgA-containing circulating immune complexes in patients with IgA nephropathy. Am J Med. 1983;74(1):56-63. [crossref]
4.
Jennette JC. The immunohistology of IgA nephropathy. Am J Kidney Dis Off J Natl Kidney Found. 1988;12(5):348-52. [crossref]
5.
Wyatt RJ, Julian BA. Activation of complement in IgA nephropathy. Am J Kidney Dis Off J Natl Kidney Found. 1988;12(5):437-42. [crossref]
6.
Daha MR, van Kooten C. Role of complement in IgA nephropathy. J Nephrol. 2016;29:01-04. [crossref] [PubMed]
7.
Gunnarsson I, Rönnelid J, Lundberg I, Jacobson SH. Occurrence of anti-C1q antibodies in IgA nephropathy. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 1997;12(11):2263-68. [crossref] [PubMed]
8.
Welch TR, McAdams J. Immunoglobulin M and C1q mesangial labeling in IgA nephropathy. Am J Kidney Dis Off J Natl Kidney Found. 1998;32(4):589-92. [crossref]
9.
Hsu SI, Ramirez SB, Winn MP, Bonventre JV, Owen WF. Evidence for genetic factors in the development and progression of IgA nephropathy. Kidney Int. 2000;57(5):1818-35. [crossref] [PubMed]
10.
D’Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol. 2004;24(3):179-96. [crossref] [PubMed]
11.
Chandrika BK. IgA nephropathy in Kerala, India: A retrospective study. Indian J Pathol Microbiol. 2009;52(1):14. [crossref] [PubMed]
12.
Roos A, Rastaldi MP, Calvaresi N, Oortwijn BD, Schlagwein N, van Gijlswijk-Janssen DJ, et al. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol JASN. 2006;17(6):1724-34. [crossref] [PubMed]
13.
Espinosa M, Ortega R, Gómez-Carrasco JM, López-Rubio F, López-Andreu M, López-Oliva MO, et al. Mesangial C4d deposition: A new prognostic factor in IgA nephropathy. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2009;24(3):886-91. [crossref] [PubMed]
14.
Lee HJ, Choi SY, Jeong KH, Sung JY, Moon SK, Moon JY, et al. Association of C1q deposition with renal outcomes in IgA nephropathy. Clin Nephrol. 2013;80(2):98-104. [crossref]
15.
Working Group of the International IgA Nephropathy Network and the Renal Pathology Society; Cattran DC, Coppo R, Cook HT, Feehally J, Roberts ISD, Troyanov S, et al. The Oxford classification of IgA nephropathy: Rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76(5):534-45.
16.
Cappellini MD, Motta I. Anemia in clinical practice-definition and classification: Does hemoglobin change with aging? Semin Hematol. 2015;52(4):261-69. [crossref] [PubMed]
17.
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute (US);2004.
18.
KDIGO_2012_CKD_GL.pdf [Internet]. [cited 2022 Mar 5]. Available from: https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf.
19.
Birmingham D, Irshaid F, Nagaraja H, Zou X, Tsao B, Wu H, et al. The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus. 2010;19(11):1272-80. [crossref] [PubMed]
20.
Nishi T, Bond C, Brown G, Solez K, Heptinstall RH. A morphometric study of arterial intimal thickening in kidneys of dialyzed patients. Am J Pathol. 1979;95(3):597-10.
21.
Renna NF, de las Heras N, Miatello RM. Pathophysiology of vascular remodeling in hypertension. Int J Hypertens. 2013;2013:e808353. [crossref] [PubMed]
22.
Katafuchi R, Nagae H, Masutani K, Tsuruya K, Mitsuiki K. Comprehensive evaluation of the significance of immunofluorescent findings on clinicopathological features in IgA nephropathy. Clin Exp Nephrol. 2019;23(2):169-81. [crossref] [PubMed]
23.
Rajasekaran A, Julian BA, Rizk DV. IgA nephropathy: An interesting autoimmune kidney disease. Am J Med Sci. 2021;361(2):176-94. [crossref] [PubMed]
24.
Khairwa A. Indian scenario of IgA nephropathy: A systematic review and meta-analysis. Afr Health Sci. 2021;21(1):159-65. [crossref] [PubMed]
25.
Ibels LS, Györy AZ. IgA nephropathy: Analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine (Baltimore). 1994;73(2):79-02. [crossref]
26.
Moriyama T, Tanaka K, Iwasaki C, Oshima Y, Ochi A, Kataoka H, et al. Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan. PLOS ONE. 2014;9(3):e91756. [crossref] [PubMed]
27.
Duan ZY, Cai GY, Chen YZ, Liang S, Liu SW, Wu J, et al. Aging promotes progression of IgA nephropathy: A systematic review and meta-analysis. Am J Nephrol. 2013;38(3):241-52. [crossref] [PubMed]
28.
Wagrowska-Danilewicz M, Danilewicz M, Szemraj M. IgA nephropathy in patients above 45 years of age. Clinical and morphologic analysis. Pol Merkur Lek Organ Pol Tow Lek. 1997;3(15):115-18.
29.
Gutiérrez E, González E, Hernández E, Morales E, Martínez MÃ, Usera G, et al. Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy. Clin J Am Soc Nephrol. 2007;2(1):51-57. [crossref] [PubMed]
30.
Radford MG, Donadio JV, Bergstralh EJ, Grande JP. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol JASN. 1997;8(2):199-07. [crossref] [PubMed]
31.
Rychlik I, Andrassy K, Waldherr R, Zuna I, Tesar V, Jancová E, et al. Clinical features and natural history of IgA nephropathy. Ann Med Interne (Paris). 1999;150(2):117-26.
32.
Geddes CC, Rauta V, Gronhagen-Riska C, Bartosik LP, Jardine AG, Ibels LS, et al. A tricontinental view of IgA nephropathy. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2003;18(8):1541-48. [crossref] [PubMed]
33.
Siddappa S, Kowsalya R, Mythri KM. IgA nephropathy in a tertiary care center from south India. Indian J Nephrol. 2011;21(4):230-34. [crossref] [PubMed]
34.
Wada Y, Ogata H, Takeshige Y, Takeshima A, Yoshida N, Yamamoto M, et al. Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy. Clin Exp Nephrol. 2013;17(1):73-82. [crossref] [PubMed]
35.
Yu GZ, Guo L, Dong JF, Shi SF, Liu LJ, Wang JW, et al. Persistent hematuria and kidney disease progression in IgA nephropathy: A cohort study. Am J Kidney Dis Off J Natl Kidney Found. 2020;76(1):90-99. [crossref] [PubMed]
36.
Coppo R, Fervenza FC. Persistent microscopic hematuria as a risk factor for progression of IgA nephropathy: New floodlight on a nearly forgotten biomarker. J Am Soc Nephrol JASN. 2017;28(10):2831-34. [crossref] [PubMed]
37.
Coppo R, D’Amico G. Factors predicting progression of IgA nephropathies. J Nephrol. 2005;18(5):503-12.
38.
Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China. Nephrol Carlton Vic. 2008;13(3):242-46. [crossref] [PubMed]
39.
Mannai K, Gaied H, Jerbi M, Trabelsi RA, Bacha M, Harzallah A, et al. Hypertension In IgA nephropathy with microangiopathy. J Hypertens. 2021;39:e299. [crossref]
40.
Nagy J, Kovács T, Wittmann I. Renal protection in IgA nephropathy requires strict blood pressure control. Nephrol Dial Transplant. 2005;20(8):1533-39. [crossref] [PubMed]
41.
Tian S, Yang X, Luo J, Guo H. Clinical and prognostic significance of C1q deposition in IgAN patients-A retrospective study. Int Immunopharmacol. 2020;88:106896. [crossref] [PubMed]
42.
Mubarak M. Oxford classification of IgA nephropathy: Broadening the scope of the classification. J Nephropathol. 2012;1(1):13-16. [crossref] [PubMed]
43.
Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, et al. Oxford classification of IgA nephropathy 2016: An update from the IgA nephropathy classification working group. Kidney Int. 2017;91(5):1014-21. [crossref] [PubMed]
44.
Tan L, Tang Y, Pei G, Zhong Z, Tan J, Zhou L, et al. A multicenter, prospective, observational study to determine association of mesangial C1q deposition with renal outcomes in IgA nephropathy. Sci Rep. 2021;11(1):5467. [crossref] [PubMed]
45.
Pei G, Zeng R, Han M, Liao P, Zhou X, Li Y, et al. Renal interstitial infiltration and tertiary lymphoid organ neogenesis in IgA nephropathy. Clin J Am Soc Nephrol CJASN. 2014;9(2):255-64. [crossref] [PubMed]
46.
Ito T, Ishikawa E, Fujimoto M, Murata T, Yamada N, Ito M. Severe intimal thickening of interlobular arteries revealed by a renal biopsy in an adult with Prader-Willi Syndrome complicated by IgA nephropathy. Intern Med Tokyo Jpn. 2016;55(2):161-64. [crossref] [PubMed]
47.
Zhang Y, Sun L, Zhou S, Xu Q, Xu Q, Liu D, et al. Intrarenal arterial lesions are associated with higher blood pressure, reduced renal function and poorer renal outcomes in patients with IgA nephropathy. Kidney Blood Press Res. 2018;43(2):639-50. [crossref] [PubMed]
48.
Dong L, Tan J, Li F, Wang S, Jiang Z, Qin A, et al. Arterial-arteriolar sclerosis is independently associated with poor renal outcome in IgA nephropathy Patients. Front Med (Lausanne). 2021;8:761897. [crossref] [PubMed]
49.
Wu J, Chen X, Xie Y, Yamanaka N, Shi S, Wu D, et al. Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2005;20(4):719-27. [crossref] [PubMed]
50.
Nishiwaki H, Hasegawa T, Nagayama Y, Kaneshima N, Takayasu M, Hirose M, et al. Absence of mesangial C1q deposition is associated with resolution of proteinuria and hematuria after tonsillectomy plus steroid pulse therapy for immunoglobulin A nephropathy. Nephron. 2015;130(1):01-07. [crossref] [PubMed]

DOI and Others

DOI: 10.7860/JCDR/2022/53066.16666

Date of Submission: Oct 29, 2021
Date of Peer Review: Dec 14, 2021
Date of Acceptance: May 28, 2022
Date of Publishing: Jul 01, 2022

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Oct 31, 2021
• Manual Googling: Jan 27, 2022
• iThenticate Software: May 23, 2022 (25%)

ETYMOLOGY: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com